SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)
17.00
-1.02 (-5.66%)
Dec 5, 2025, 3:04 PM CET
FRA:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 256.46M EUR in the quarter ending June 30, 2025, with 1.13% growth. This brings the company's revenue in the last twelve months to 975.68M, up 2.86% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.
Revenue (ttm)
975.68M
Revenue Growth
+2.86%
P/S Ratio
2.62
Revenue / Employee
204.33K
Employees
4,690
Market Cap
2.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.27B |
| Siemens Healthineers AG | 23.38B |
| Bayer Aktiengesellschaft | 45.87B |
| Fresenius SE & Co. KGaA | 22.45B |
| Sartorius Aktiengesellschaft | 3.52B |
| Fresenius Medical Care AG | 19.64B |
| Carl Zeiss Meditec AG | 2.18B |
| Fielmann Group AG | 2.42B |
SCHOTT Pharma AG & Co. KGaA News
- 1 day ago - SCHOTT Pharma Projects 5.8% Revenue Growth In 2025 - Nasdaq
- 2 days ago - SCHOTT Pharma Reports FY 2025 Results, Outlook FY 2026 & Guidance Update - Wallstreet:Online
- 2 days ago - EQS-News: SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance - Wallstreet:Online
- 2 days ago - SCHOTT Pharma's 2026 Outlook & Mid-Term Guidance Update - Wallstreet:Online
- 2 days ago - EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance - Wallstreet:Online
- 4 weeks ago - EQS-News: SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma - Wallstreet:Online
- 4 weeks ago - EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO - Wallstreet:Online
- 4 weeks ago - EQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online